These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 9354451

  • 1. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK.
    Cancer Res; 1997 Nov 01; 57(21):4868-75. PubMed ID: 9354451
    [Abstract] [Full Text] [Related]

  • 2. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM, Welch J, Hayward NK.
    Cancer Res; 2001 Feb 01; 61(3):1154-61. PubMed ID: 11221846
    [Abstract] [Full Text] [Related]

  • 3. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.
    Glendening JM, Flores JF, Walker GJ, Stone S, Albino AP, Fountain JW.
    Cancer Res; 1995 Dec 01; 55(23):5531-5. PubMed ID: 7585628
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds.
    Flores JF, Pollock PM, Walker GJ, Glendening JM, Lin AH, Palmer JM, Walters MK, Hayward NK, Fountain JW.
    Oncogene; 1997 Dec 11; 15(24):2999-3005. PubMed ID: 9416844
    [Abstract] [Full Text] [Related]

  • 5. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
    Merbs SL, Sidransky D.
    Invest Ophthalmol Vis Sci; 1999 Mar 11; 40(3):779-83. PubMed ID: 10067984
    [Abstract] [Full Text] [Related]

  • 6. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
    Biden K, Young J, Buttenshaw R, Searle J, Cooksley G, Xu DB, Leggett B.
    Hepatology; 1997 Mar 11; 25(3):593-7. PubMed ID: 9049204
    [Abstract] [Full Text] [Related]

  • 7. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 11; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 8. CDKN2A mutation and deletion status in thin and thick primary melanoma.
    Cachia AR, Indsto JO, McLaren KM, Mann GJ, Arends MJ.
    Clin Cancer Res; 2000 Sep 11; 6(9):3511-5. PubMed ID: 10999737
    [Abstract] [Full Text] [Related]

  • 9. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K, Yokota J.
    Cancer Res; 1997 Mar 01; 57(5):907-12. PubMed ID: 9041193
    [Abstract] [Full Text] [Related]

  • 10. CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
    Ruiz A, Puig S, Malvehy J, Lázaro C, Lynch M, Gimenez-Arnau AM, Puig L, Sánchez-Conejo J, Estivill X, Castel T.
    J Med Genet; 1999 Jun 01; 36(6):490-3. PubMed ID: 10874641
    [Abstract] [Full Text] [Related]

  • 11. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
    Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS.
    Cancer Res; 2001 Jan 15; 61(2):679-86. PubMed ID: 11212268
    [Abstract] [Full Text] [Related]

  • 12. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE, Fountain JW.
    Cancer Res; 1996 Nov 01; 56(21):5023-32. PubMed ID: 8895759
    [Abstract] [Full Text] [Related]

  • 13. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 14. Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells.
    Zhang H, Rosdahl I.
    Int J Oncol; 2004 Feb 01; 24(2):331-5. PubMed ID: 14719109
    [Abstract] [Full Text] [Related]

  • 15. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ, Aldaz CM.
    Cancer Res; 1995 Jul 01; 55(13):2892-5. PubMed ID: 7796417
    [Abstract] [Full Text] [Related]

  • 16. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereux TR.
    Clin Cancer Res; 1995 Jul 01; 1(7):687-90. PubMed ID: 9816033
    [Abstract] [Full Text] [Related]

  • 17. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 18. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
    Knappskog S, Geisler J, Arnesen T, Lillehaug JR, Lønning PE.
    Genes Chromosomes Cancer; 2006 Dec 15; 45(12):1155-63. PubMed ID: 17001621
    [Abstract] [Full Text] [Related]

  • 19. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway.
    Berner JM, Sørlie T, Mertens F, Henriksen J, Saeter G, Mandahl N, Brøgger A, Myklebost O, Lothe RA.
    Genes Chromosomes Cancer; 1999 Oct 15; 26(2):151-60. PubMed ID: 10469453
    [Abstract] [Full Text] [Related]

  • 20. Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
    McKenzie HA, Fung C, Becker TM, Irvine M, Mann GJ, Kefford RF, Rizos H.
    Hum Mutat; 2010 Jun 15; 31(6):692-701. PubMed ID: 20340136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.